​​​​​​​Watch now: Why GLP-1 Drugs Are A Big Deal for FMCG Companies and the Sugar Industry

Your details

Subscribing to

Register to start watching


Why GLP-1 Drugs Are A Big Deal for FMCG Companies and the Sugar Industry

GLP-1 drugs like Ozempic and Wegovy are going mainstream. One in eight Americans have now tried them. Yet there’s surprisingly little discussion about them in the sugar and food/beverage industries. We think their usage should be taken more seriously and could re-shape food consumption and energy production.

​​​​​​​Join us for this webinar where we look into this topic further.
​​​​​​​
CZ Advise
Speaker
Stephen Geldart
Associate Director, Head of Analysis
​​​​​​​
Duration
20 minutes + Q&A

Share this webinar